Impact of reduced tigecycline susceptibility on clinical outcomes of Acinetobacter bacteremia

被引：3
作者：
Chang, Yea-Yuan [1 ,2 ,3 ]
Liu, Yuag-Meng [4 ]
Liu, Chang-Pan [5 ]
Kuo, Shu-Chen [3 ,6 ]
Chen, Te-Li [3 ,7 ]
机构：
[1] Natl Yang Ming Univ Hosp, Dept Med, Div Infect Dis, Yilan, Taiwan
[2] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan
[3] Taipei Vet Gen Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan
[4] Changhua Christian Hosp, Dept Internal Med, Div Infect Dis, Changhua, Taiwan
[5] MacKay Mem Hosp, Dept Internal Med, Div Infect Dis, Taipei, Taiwan
[6] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, 35 Keyan Rd, Zhunan Town 350, Miaoli County, Taiwan
[7] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan
来源：
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION | 2018年 / 51卷 / 01期
关键词：
Tigecycline; Acinetobacter bacteremia; Minimum inhibitory concentration; Appropriate antibiotics; PROGRAM;
D O I：
10.1016/j.jmii.2017.08.024
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The higher 14-day mortality rate for patients with Acinetobacter bacteremia receiving tigecycline appropriately compared to other appropriate antibiotics (36.4% versus 14.2%, P = 0.028) was due to the poor effect of tigecycline for isolates with a minimum inhibitory concentration of 2 mg/mL (63.6% of 11 versus 14.2% of 127, P = 0.001). Copyright (C) 2017, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
引用
收藏
页码：148 / 152
页数：5
相关论文
共 50 条
  • [21] Clinical Experience with Tigecycline in the Treatment of Carbapenem-Resistant Acinetobacter Infections
    Metan, G.
    Alp, E.
    Yildiz, O.
    Percin, D.
    Aygen, B.
    Sumerkan, B.
    JOURNAL OF CHEMOTHERAPY, 2010, 22 (02) : 110 - 114
  • [22] Molecular Characterization of Tigecycline Non-Susceptibility among Extensively Drug-Resistant Acinetobacter baumannii Isolates of Clinical Origin
    Haeili, Mehri
    Abdollahi, Ali
    Ahmadi, Amin
    Khoshbayan, Amin
    CHEMOTHERAPY, 2021, 66 (03) : 99 - 105
  • [23] Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii
    Schafer, Jason J.
    Goff, Debra A.
    Stevenson, Kurt B.
    Mangino, Julie E.
    PHARMACOTHERAPY, 2007, 27 (07): : 980 - 987
  • [24] Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates
    Piewngam, Pipat
    Kiratisin, Pattarachai
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 44 (05) : 396 - 401
  • [25] In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan
    Liu, Jien-Wei
    Wang, Lih-Shinn
    Cheng, Yu-Jen
    Hsu, Gwo-Jong
    Lu, Po-Liang
    Liu, Yung-Ching
    Chen, Chih-Ming
    Lee, Chun-Ming
    Sun, Wu
    Jang, Tsrang-Neng
    Chiang, Ping-Cherng
    Chuang, Yin-Ching
    Lin, Hsiu-Chen
    Shi, Zhi-Yuan
    Kung, Hsiang-Chi
    Huang, Cheng-Hua
    Tsao, Shih-Ming
    Lu, Chin-Te
    Liao, Chun-Hsing
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 : S188 - S191
  • [26] The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia
    Honda, Hitoshi
    Doern, Christopher D.
    Michael-Dunne, Wm, Jr.
    Warren, David K.
    BMC INFECTIOUS DISEASES, 2011, 11
  • [27] Evaluation of Tigecycline Susceptibility by E-Test (R) in Multidrug-Resistant Acinetobacter baumannii Isolates
    Kuscu, Ferit
    Ozturk, D. Baris
    Tutuncu, E. Ediz
    Uslu, Meral
    Gurbuz, Yunus
    Gulen, Gonul
    Sencan, Irfan
    KLIMIK JOURNAL, 2009, 22 (02) : 48 - 51
  • [28] Tigecycline susceptibility of multidrug-resistant Acinetobacter baumannii from intensive care units in the western Balkans
    Gajic, Ina
    Ranin, Lazar
    Kekic, Dusan
    Opavski, Natasa
    Smitran, Aleksandra
    Mijac, Vera
    Jovanovic, Snezana
    Hadnadjev, Mirjana
    Travar, Maja
    Mijovic, Gordana
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2020, 67 (03) : 176 - 181
  • [29] In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008
    Wang, Yun F.
    Dowzicky, Michael J.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2010, 68 (01) : 73 - 79
  • [30] Clinical and microbiological characteristics of tigecycline non-susceptible Klebsiella pneumoniae bacteremia in Taiwan
    Lin, Yi-Tsung
    Wang, Fu-Der
    Chan, Yu-Jiun
    Fu, Yung-Chieh
    Fung, Chang-Phone
    BMC INFECTIOUS DISEASES, 2014, 14
12345